Résultats de la recherche - 97 results

Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework

clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

safety of prophylactic HPV vaccines derived from randomized trials was published in the Cochrane database of Systematic reviews. A summary of this Cochrane review is presented below. Areas covered: Only ...

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.

precancer. However, insufficient evidence is available for specific HPV assay/self-sample device combinations. OBJECTIVES: The VALHUDES protocol is designed as a diagnostic test accuracy study that aims to ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. VALGENT is designed to assess ...

Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.

Human papillomavirus (HPV) testing is being increasingly incorporated into cervical cancer screening. VALGENT (VAL idation of HPV GEN otyping Tests) is a framework designed to evaluate the clinical ...

Defining optimal triage strategies for hrHPV screen positive women- an evaluation of HPV 16/18 genotyping, cytology and p16/Ki-67 cyto-immunochemistry.

Govan, Lynn; Black, Janice; Palmer, Tim; Arbyn, Marc Source: Cancer Epidemiol Biomarkers Prev (2017) Abstract: BACKGROUND: Several options for the triage of high-risk HPV screen positive (hrHPV+) women ...

Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.

and Neck Neoplasms Humans India Male middle aged Papillomaviridae Papillomavirus Infections Abstract: Mucosal high-risk (HR) human papillomaviruses (HPV) cause a subset of head and neck cancers (HNC). ...

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.

Human papillomaviruses (HPV s) are the necessary cause of most cervical cancers, a large proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The knowledge about HPV has led to ...

Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.

Squamous Intraepithelial Lesions of the Cervix Uterine Cervical Neoplasms Vaginal Smears Abstract: BACKGROUND: In 2014, liquid-based cytology with HPV triage replaced conventional cytology. The aim of our ...

HPV-based cervical cancer screening- facts, fiction, and misperceptions.

HPV-based cervical cancer screening is more effective than cytology-based screening. A pooled analysis of long-term follow-up data from these trials has shown reduced cervical cancer mortality in women ...

QR code

QR code for this page URL